“IT'S A NIGHTMARE!” That's how one CME provider described the new commercial support process to me. As a reaction to the OIG pharma marketing guidance, legal and compliance departments are now directing funding procedures, disrupting long-standing relationships between sales reps and CME providers, and creating confusing, time-consuming guidelines.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments